Study performed at the Department of Dermatology, 12 de Octubre University Hospital, Madrid, Spain.

For decades, unfractionated heparin (hereafter, heparin) has been the primary anticoagulant used for extracorporeal membrane oxygenation (ECMO) support. More recently, however, bivalirudin, a direct ...

The HELP-PCI trial evaluated the impact of early administration of unfractionated heparin in patients with STEMI. The trial showed that early heparin administration improved myocardial blood flow but ...

Objective and Design: Tinzaparin and dalteparin are low molecular weight heparins (LMWHs) with different pharmacokinetic and pharmacodynamic profiles that may lead to differences in efficacy and ...

Both cerebral venous thrombosis and pelvic vein thrombosis were effectively treated with unfractionated heparin started on the day of admission, then shifted to low molecular weight heparin, with a ...

Currently approved anticoagulants for treatment of patients with coronary artery disease manifestations include unfractionated heparin, low-molecular-weight heparins, bivalirudin, and fondaparinux.